Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
R42 Fund 1, Lp investment portfolio
R42 Fund 1, Lp has made numerous investments in companies such as Spirea, Senisca, and Exseed Health within the Biotech sector.
vc
Portfolio
7
Team
0
Portfolio (7)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Concr Ltd Concr delivers predictive‑modelling solutions that apply Bayesian AI‑driven digital‑twin simulations to forecast individual patient responses to cancer therapies, supporting more informed drug development and treatment decisions. Its platform is used by pharmaceutical companies, research institutes and healthcare organisations developing or evaluating oncology drugs. | Software & IT | London | Confirmed | 2026-04-23 |
| Exseed Health Limited ExSeed Health develops and provides an at‑home male fertility testing kit combined with a digital health platform, offering men a convenient way to assess their sperm health and access related fertility services. | Software & IT | London | Confirmed | 2025-10-08 |
Shareholding changes (7)
R42 Fund 1, Lp's positions across portfolio companies2026
- ORDINARY 26,960 → 24,606
2025
- ORDINARY 360,243 → 148,286
Articles (2)
- 11 Jul 2026
- 16 May 2026